Search Results - "Chiu, Christopher W"

Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis by CHIU, Christopher W, NOZAWA, Hiroaki, HANAHAN, Douglas

“…Pancreatic neuroendocrine tumors (PNETs), although rare, often metastasize, such that surgery, the only potentially curative therapy, is not possible. There is…”
Get full text

Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis by Chun, Matthew G. H., Mao, Jian-Hua, Chiu, Christopher W., Balmain, Allan, Hanahan, Douglas

“…Cancer is a disease subject to both genetic and environmental influences. In this study, we used the RIP1-Tag2 (RT2) mouse model of islet cell carcinogenesis…”
Get full text

A Method for Analyzing Sparse Data Matrices in the Generalizability Theory Framework by Chiu, Christopher W. T., Wolfe, Edward W.

“…In generalizability analyses, unstable, and potentially invalid, variance component estimates may result from using only a limited portion of available data…”
Get full text

BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins by Chiu, Christopher W., Dalton, Mark, Ishiai, Masamichi, Kurosaki, Tomohiro, Chan, Andrew C.

“…Assembly of intracellular macromolecular complexes is thought to provide an important mechanism to coordinate the generation of second messengers upon receptor…”
Get full text

Identification of Optimal Dosing Regimen for Subcutaneous Epcoritamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma by Li, Tommy, Gibiansky, Leonid, Parikh, Apurvasena, Chiu, Christopher W., Sacchi, Mariana, Feng, Huaibao, Ahmadi, Tahi, Gupta, Manish, Xu, Steven

“…Background: Epcoritamab SC, a CD3xCD20 bispecific antibody developed using the DuoBody ® platform, engages T cells to target CD20-expressing B cells…”
Get full text

Evaluation of Epcoritamab and Rituximab Combination in Preclinical Models of B-Cell Non-Hodgkin's Lymphoma (NHL) by Epling-Burnette, PK, Dandamudi, Durga B, Konieczna, Iwona M, Calabrese, Kelly M, Wielgos-Bonvallet, Monica, Kweekel, Christiaan, Gresnigt - van den Heuvel, Elke, Parikh, Apurvasena, Li, Tommy, Chiu, Christopher W, Chervin, Adam, Reilly, Edward B, Szafer-Glusman, Edith

Get full text

Abstract 1574: Preclinical evaluation of epcoritamab combined with standard of care therapies for the treatment of B-cell lymphomas by Chiu, Christopher W., Hiemstra, Ida H., Hagen, Wessel ten, Snijdewint-Nkairi, Rajaa, de Jong, Bart, Oliveri, Roberto S., Elliot, Brian, Szafer-Glusman, Edith, Schuurhuis, Danita, Blaedel, Julie, Ahmadi, Tahamatan, Breij, Esther, Sasser, A. Kate, Jure-Kunkel, Maria

“…B-cell non-Hodgkin lymphoma (B-NHL) is a heterogeneous disease with an unmet medical need for new efficacious, well tolerated, off-the-shelf therapies that can…”
Get full text

Visualizing Large-Scale Data in Educational, Behavioral, Psychometrical and Social Sciences: Utilities and Design Patterns of the SEER Computational and Graphical Statistics by Chiu, Christopher WT, Pashley, Peter, Seastrom, Marilyn, Carr, Peggy

“…This paper introduces a graphical method SEE Repeated-measure data (SEER) to visually analyze data commonly collected in large-scale surveys, market research,…”
Get full text

Abstract 3732: Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab + lenalidomide in patients with follicular lymphoma by Si, Han, Zhang, Jimin, Wielgos-Bonvallet, Monica, Falchi, Lorenzo, Linton, Kim, Jurczak, Wojciech, Belada, David, Altıntaş, Işıl, Sacchi, Mariana, Favaro, Elena, Rana, Ali, Hoehn, Daniela, Soong, David, Chiu, Christopher W., Jure-Kunkel, Maria

“…Introduction: Epcoritamab (DuoBody®-CD3xCD20) is a subcutaneous IgG1 bispecific antibody that simultaneously binds to CD3 on T cells and CD20 on malignant B…”
Get full text

The Influence of Recovery Status and Education on Addiction Counselors' Approach to Treatment by Stöffelmayr, Bertram E., Mavis, Brian E., Sherry, Laura A., Chiu, Christopher W.

“…The goal of this study is to examine the influence of education and recovery status on substance abuse treatment counselors' approach to patients. Three…”
Get full text

Abstract 3248: Pharmacodynamic activity of epcoritamab (GEN3013; CD3xCD20) as monotherapy is maintained in combination with standard of care therapies in patients with diffuse large B-cell lymphoma by Zhang, Jimin, Si, Han, Wielgos-Bonvallet, Monica, Soong, David, Szafer-Glusman, Edith, Ghesquieres, Herve, Cheah, Chan Y., Falchi, Lorenzo, Brody, Joshua, Sacchi, Mariana, Rana, Ali, Higgs, Brandon, Elliot, Brian, Jure-Kunkel, Maria, Chiu, Christopher W.

“…Introduction: B-cell lymphoma is a heterogeneous disease with an unmet medical need for efficacious, well tolerated, off-the-shelf therapies that can combine…”
Get full text

A Subdividing Method for Generalizability Theory: Precision of Measurement Errors and Patterns of Missing Data by Chiu, Christopher W. T

“…A procedure was developed to analyze data with missing observations by extracting data from a sparsely filled data matrix into analyzable smaller subsets of…”
Get more information